{
  "trial_id": "NCT02433977",
  "trial_group": "obesity",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race/ethnicity, BMI, smoking history, baseline FEV1, bronchodilator response, PC20 methacholine, ICS/ICS LABA therapy status, asthma diagnosis duration, history of respiratory tract infection, history of oral or systemic corticosteroid use, history of asthma-related hospitalization, history of asthma-related ER visit, presence of significant or uncontrolled concomitant medical illness, renal function (creatinine levels), statin use, pregnancy status, allergy to intervention drugs, investigational treatment study participation, use of oral nitrates, history of ICU admission/intubation due to asthma, frequency of systemic corticosteroid requiring asthma exacerbations, systemic steroid dependency, use of mouthwash containing chlorhexidine, sleep apnea status, Hgb A1C levels, use of PPIs or H2 blockers, use of biologics for asthma/allergies, drug and/or alcohol abuse history, breastfeeding status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "race/ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "BMI",
        "smoking history",
        "baseline FEV1",
        "bronchodilator response",
        "PC20 methacholine",
        "ICS/ICS LABA therapy status",
        "asthma diagnosis duration",
        "history of respiratory tract infection",
        "history of oral or systemic corticosteroid use",
        "history of asthma-related hospitalization",
        "history of asthma-related ER visit",
        "presence of significant or uncontrolled concomitant medical illness",
        "renal function (creatinine levels)",
        "statin use",
        "pregnancy status",
        "allergy to intervention drugs",
        "investigational treatment study participation",
        "use of oral nitrates",
        "history of ICU admission/intubation due to asthma",
        "frequency of systemic corticosteroid requiring asthma exacerbations",
        "systemic steroid dependency",
        "use of mouthwash containing chlorhexidine",
        "sleep apnea status",
        "Hgb A1C levels",
        "use of PPIs or H2 blockers",
        "use of biologics for asthma/allergies",
        "drug and/or alcohol abuse history",
        "breastfeeding status"
      ]
    },
    "processed-gen-response": "Age, gender, race/ethnicity, BMI, smoking history, baseline FEV1, bronchodilator response, PC20 methacholine, ICS/ICS LABA therapy status, asthma diagnosis duration, history of respiratory tract infection, history of oral or systemic corticosteroid use, history of asthma-related hospitalization, history of asthma-related ER visit, presence of significant or uncontrolled concomitant medical illness, renal function (creatinine levels), statin use, pregnancy status, allergy to intervention drugs, investigational treatment study participation, use of oral nitrates, history of ICU admission/intubation due to asthma, frequency of systemic corticosteroid requiring asthma exacerbations, systemic steroid dependency, use of mouthwash containing chlorhexidine, sleep apnea status, Hgb A1C levels, use of PPIs or H2 blockers, use of biologics for asthma/allergies, drug and/or alcohol abuse history, breastfeeding status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Smoking history, Baseline FEV1, Bronchodilator response, PC20 methacholine, Asthma diagnosis duration, ICS/ICS LABA therapy status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Smoking history",
        "Baseline FEV1",
        "Bronchodilator response",
        "PC20 methacholine",
        "Asthma diagnosis duration",
        "ICS/ICS LABA therapy status"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Body Mass Index, Smoking history, Baseline FEV1, Bronchodilator response, PC20 methacholine, Asthma diagnosis duration, ICS/ICS LABA therapy status"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Asthma Diagnosis Duration, Smoking History, FEV1, Bronchodilator Response, PC20 Methacholine, ICS/ICS LABA Therapy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Asthma Diagnosis Duration",
        "Smoking History",
        "FEV1",
        "Bronchodilator Response",
        "PC20 Methacholine",
        "ICS/ICS LABA Therapy"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Asthma Diagnosis Duration, Smoking History, FEV1, Bronchodilator Response, PC20 Methacholine, ICS/ICS LABA Therapy"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, BMI, smoking history, pack years, asthma diagnosis age, asthma duration, FEV1, bronchodilator response, PC20 methacholine, ICS/ICS LABA use, statin use, comorbidities (heart disease, cancer, diabetes, etc.), creatinine level, Hgb A1C, sleep apnea status, GERD status, biologics use, oral corticosteroid use, asthma exacerbation history, ICU admission history, intubation history.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "BMI",
        "smoking history",
        "pack years",
        "asthma diagnosis age",
        "asthma duration",
        "FEV1",
        "bronchodilator response",
        "PC20 methacholine",
        "ICS/ICS LABA use",
        "statin use",
        "comorbidities (heart disease, cancer, diabetes, etc.)",
        "creatinine level",
        "Hgb A1C",
        "sleep apnea status",
        "GERD status",
        "biologics use",
        "oral corticosteroid use",
        "asthma exacerbation history",
        "ICU admission history",
        "intubation history"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, BMI, smoking history, pack years, asthma diagnosis age, asthma duration, FEV1, bronchodilator response, PC20 methacholine, ICS/ICS LABA use, statin use, comorbidities (heart disease, cancer, diabetes, etc.), creatinine level, Hgb A1C, sleep apnea status, GERD status, biologics use, oral corticosteroid use, asthma exacerbation history, ICU admission history, intubation history."
  }
}